Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Hemorrhagic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04673422
What this trial is testing

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

Who this might be right for
DengueDengue With Warning SignsDengue Shock Syndrome
Phramongkutklao College of Medicine and Hospital 358
Not applicableStudy completedNCT01293331
What this trial is testing

Study of Febrile Illness for Dengue-Endemic Areas in Latin America

Who this might be right for
Dengue FeverFever
Sanofi 3,000
Not applicableNot Yet RecruitingNCT06432855
What this trial is testing

Genetic Determinants of the Antiviral Immune Response in Oceanian Populations

Who this might be right for
Virus
Institut Pasteur 220
Early research (Phase 1)Study completedNCT05268302
What this trial is testing

Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)

Who this might be right for
Dengue
University of Maryland, Baltimore 20
Not applicableStudy completedNCT01983553
What this trial is testing

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 3,203
Large-scale testing (Phase 3)Study completedNCT03341637
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Who this might be right for
Dengue
Takeda 400
Not applicableStudy completedNCT02827162
What this trial is testing

Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine

Who this might be right for
Dengue FeverDengue Haemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 334
Not applicableActive Not RecruitingNCT06651372
What this trial is testing

The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers

Who this might be right for
Arbovirus Infections
University Hospital, Strasbourg, France 200
Large-scale testing (Phase 3)Study completedNCT01254422
What this trial is testing

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi 250
Early research (Phase 1)Looking for participantsNCT07706686
What this trial is testing

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

Who this might be right for
Healthy VolunteersDengueHuman Challenge Trial
National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)Study completedNCT01619969
What this trial is testing

Celgosivir as a Treatment Against Dengue

Who this might be right for
Dengue Fever
Singapore General Hospital 50
Early research (Phase 1)Study completedNCT00094705
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)UnknownNCT06071481
What this trial is testing

Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome

Who this might be right for
Dengue Fever
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 120
Testing effectiveness (Phase 2)Study completedNCT00350337
What this trial is testing

Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults

Who this might be right for
Dengue
U.S. Army Medical Research and Development Command 86
Not applicableNot Yet RecruitingNCT07203183
What this trial is testing

Dengue - Sample Collection Study Pakistan

Who this might be right for
Dengue
Abbott Rapid Dx 200
Not applicableUnknownNCT04837430
What this trial is testing

NT-proBNP and Troponin I in Dengue Children

Who this might be right for
Dengue Shock SyndromeChildren, Only
Le Phuoc Truyen 90
Not applicableNot Yet RecruitingNCT06859619
What this trial is testing

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Who this might be right for
LeishmaniasisLeptospirosisBrucellosis+15 more
University Hospital, Montpellier 183
Not applicableEnded earlyNCT02766088
What this trial is testing

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

Who this might be right for
DengueDengue Vaccines
GlaxoSmithKline 1,750
Not applicableUnknownNCT00688389
What this trial is testing

Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection

Who this might be right for
Dengue Fever
Kaohsiung Medical University Chung-Ho Memorial Hospital 700
Large-scale testing (Phase 3)Study completedNCT06741683
What this trial is testing

Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan

Who this might be right for
Dengue Fever
Takeda 187
Next Page